Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
Kuros submits regulatory filing seeking CE certification for Neuroseal, a novel dural sealant
Kuros to acquire Xpand in an all-share strategic transaction to create a leading commercial stage orthobiologics company
Kuros Biosciences’ KUR-112 Receives Rare Pediatric Disease Designation
Kuros Biosciences Reports Financial Results for First Half-Year of 2016
Arbutus terminates license agreement for VLP platform for the treatment of hepatitis B infections
Kuros appoints Philippe Saudan as Chief Development Officer